Access to ALL Appropriate Treatments for ALL Heart Valve Disease Patients: TAVR NCD Infographic
Published July 18, 2018
The National Heart Valve Disease Policy Task Force believes that ALL heart valve disease patients should have access to ALL appropriate treatments. This infographic, produced by the Task Force, focuses on the burden of heart valve disease, the value of transcatheter aortic valve replacement, current CMS National Coverage Determination requirements for TAVR, timeline of the reopened NCD process, MEDCAC panel details, data on unequal access to TAVR, the potential impact on access by changes to volume requirements, and the priorities of the Task Force.